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INTRODUCTION
Primary ovarian smooth muscle tumors account
for less than 1% of all ovarian tumors (1, 2). How-
ever, there are no histological criteria for evaluat-
ing them. Currently, the histological criteria used to
evaluate the smooth muscle tumors of uterus are ap-
plied to ovary (2-4). Those tumors are uncommon
tumors that exhibit varied histological patterns, and
there is discordance between their morphologic fea-
tures (mitotic index, coagulative tumor cell necro-
sis, and atypia) and clinical outcomes. For example,
sometimes we encounter a benign tumor with aber-
rant cytological features with high mitotic counts.
Among those smooth muscle tumors, uterine smooth
muscle tumors of uncertain malignant potiential
(STUMP) are difficult tumors for the diagnosis be-
cause they cannot be classified as benign nor malig-
nant by histological criteria (3). Despite this uncer-
tain histological evidence, histological diagnosis is
still regarded as the important information in its
clinical management and treatment.
In this paper, we present a case of an ovarian
smooth muscle tumor whose diagnosis was difficult
to distinguish their malignant potential.
CASE REPORT
A 62-year-old woman (gravida 2, para 2) who had
been in menopause for 12 years visited the outpa-
tient clinic of internal medicine in our hospital on
September 25, 2008. She had complained of 5 kg
weight loss, a slight fever, loss of appetite for a
month. Gastroduodenoscopy did not reveal any ab-
normalities in her upper gastrointestine. However, a
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huge mass was palpated from pelvis extended to the
xiphisternum, and a computed tomography (CT)
scan of her abdomen and pelvis revealed the pres-
ence of a huge solid tumor which arose out of the
pelvis and extended to the xiphisternum. This huge
tumor seemed to be originated from the one side
ovary. She was introduced to our outpatient clinic to
have a gynecologic examination.
The pelvic examination and transvaginal ultra-
sound (US) revealed the presence of a huge solid tu-
mor with a hypoechoic irregular area. The tumor
was hard and easily palpated through the abdominal
wall, of which movability was limited. These findings
suggested the possible malignant potential of this tu-
mor. However, US revealed that this tumor did not
accompanied with large amount of ascites and labo-
ratory tests showed that the levels of serum tumor
markers (CA125, CA72-4, CA19-9, and CEA) or
LDH were all within the normal range. The CT scan
revealed that the tumor had an irregular shape with
a smooth border and consisted of both solid and cys-
tic part. It occupied almost whole the pelvis and
grew out to the extrapelvic space. Additionally, no
signs of distant metastasis or pelvic lymphadenopa-
thy were observed on the scan. Pelvic magnetic
resonance image (MRI) was also performed. On T1-
weighted images, the tumor showed low signal in-
tensity, while on T2-weighted images, the signal in-
tensity remained high. One area of a small part of
the tumor showed cystic changes that were often as-
sociated with a hemorrhage or necrosis (Fig. 1).
The differential diagnosis of this huge tumor in-
cluded leiomyoma, leiomyosarcoma, ovarian solid
tumor, ovarian cancer, and gastrointestinal smooth
muscle tumor (GIST). On October 27 in 2008, a la-
parotomy was performed.
SURGICAL SPECIMENS
The huge tumor occupied almost the entire ab-
domen (Fig. 2). However, only small amount of
ascites was observed. The tumor was found to ad-
here to the omentum and mesentry. It was origi-
nated from the right ovary, extending to the retrop-
eritoneal space under the broad ligament. She un-
derwent a right salpingo-oophorectomy (RSO). The
rapid histology revealed that it was a low grade ma-
lignancy of right ovarian tumor. We did not perform
the extirpation of the uterus, left adnexae, omentum,
upper abdomen, and retroperitoneal lymph nodes.
Before the operation, deep vein thrombosis (DVT)
at the renal vein was detected. Additionally, broad
adhesion of this tumor to the vessels in the retrop-
eritoneal space and mesentry caused the increased
blood loss and prolongation of the operation. Thus
further operation besides RSO should not be per-
formed. We thought that it would be better to per-
form further operation later after obtaining the final
precise histological diagnosis of this ovarian tumor.
GROSS FINDINGS
The tumor measured 25 cm in diameter and
weighed 6,200 g. Its surface was irregular, and the
cut surface was firm and white. Focal irregular cystic
and necrotic areas were present, while hemorrhagic
areas were absent (Fig. 3).
a b
Fig. 1 T2-weighted MR images showing a huge pelvic hetero-
geneous mass (a) and T1-weighted fat -suppressed gadolinium-
enhanced MR images showing cystic changes (arrow) associated
with hemorrhage or necrosis (b).
Fig. 2 Surgical specimen. The huge tumor extended from the
pelvic to the xiphisternal area.
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HISTOPATHOLOGICAL AND IMMUNOHIS-
TOCHEMICAL FINDINGS
Histological examination of the tumor showed
that it was composed of fascicles of spindle-shaped
cells with moderate to severe cellular atypia and in-
creased cellularity, but no coagulative necrosis or ex-
cessive number of mitotic figures (2 to 3/10 HPF).
Immunohistochemical examination of the tumor
cells showed that they were positive for α -smooth
muscle actin and desmin. The MIB-1 labeling index
was approximately 10%. Although coagulative necro-
sis was not present, and mitotic activity was moder-
ate, a final diagnosis of STUMP was made on the ba-
sis of cellular atypia, increased cellularity, and tumor
size (Figs. 4, 5).
Fig. 3 Macroscopic findings for the extirpated tumor. The ex-
ternal surface was irregular and nodular. The arrow shows cys-
tic areas.
a b c
Fig. 5 The tumor cells were positive for (a) a-smooth muscle actin and (b) desmin. (c) The MIB-1 labeling index was approximately
10%. Scale bars, 50 mm.
a b
Fig. 4 (a) The tumor is composed of fascicles of spindle-shaped cells (HE). (b) Multinucleated tumor cells with hyperchromatic
nuclei. Cellular atypia is graded as moderate to severe (HE). Scale bars, 50 mm.
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POSTOPERATIVE CLINICAL COURSE
The patient and her family were informed of the
fact that the effect of additional surgery on survival
in patients of STUMP had not been shown because
the tumor of low-grade malignancy generally did not
metastasize. They were also informed that the effec-
tiveness of chemotherapy or radiation for STUMP
was not known even in case any metastasis existed.
After the careful consideration, they finally did not
agree with an additional surgery, adjuvant chemo-
therapy, or radiation therapy.
She has been observed in our outpatient clinic
and for the time being, relapse has not been de-
tected 5 months after the operation.
DISCUSSION
Primary ovarian smooth muscle tumors are very
rare tumors in comparison with the uterine smooth
muscle tumors (1). There is little information on
their origin, etiology, histological features, clinical
behavior, and treatment (5). Furthermore, there are
no determinant histological criteria for evaluation.
Thus, there are some reports that they can be iden-
tified on the basis of criteria similar to those used
for uterine smooth muscle tumors (2-5).
Uterine smooth muscle tumors are classified into
the following groups : leiomyoma, mitotically active
leiomyoma, atypical leiomyoma, leiomyosarcoma,
and STUMP. If tumor cell atypia is absent or most
mild without necrosis, the tumor is leiomyoma.
There is no need to use mitotic index (MI) if atypia
and coagulative necrosis are clearly absent. In case
that MI of the leiomyoma is more than 10, the tu-
mor is specially called as the mitotic active leio-
myoma. If tumor cell atypia is moderate or severe
without necrosis, the tumor is classified according
to the MI. If the MI is less than 10, it is classified
as atypical leiomyoma. If MI is more than 10, it is
classified as leiomyosarcoma. When both significant
atypia and coagulative necrosis are present, the tu-
mor is leiomyosarcoma regardless of the MI. (2). If
the tumor shows the problematic clinical and his-
tological features that can not led the clear classifi-
cation into benign nor malignant category, it is clas-
sifed as smooth muscle tumor of uncertain malig-
nant potential (STUMP). According to these criteria
of uterine smooth muscle tumors, this case should
be classified as atypical leiomyoma because the cel-
lular atypia is moderate to severe without necrosis,
and the MI is 2 to 3. Generally, malignant potential
behavior of smooth muscle tumors is almost always
associated with any two of the following features :
coagulative necrosis, cellular atypia, and MI10
(3). The tumor size is not considered. However, in
this case, we made the diagnosis as STUMP, not
atypical leiomyoma. Because the size of this tumor
was, to our knowladge, the hugest in the reported
cases, we were reluctant to apply the criteria of uter-
ine smooth muscle tumors to this ovarian tumor.
The International Federation of Gynecology and
Obstetrics (FIGO) staging and treatment of ovarian
leiomyosarcoma have been the same as those for
ovarian carcinoma (6). There is no established treat-
ment for them other than surgery (7). About the
treatment of uterine leiomyosarcoma, adjuvant che-
motherapy or radiation therapy after the primary
surgery is often performed. Those therapies of uter-
ine disease should be applied to the ovarian leio-
myosarcoma, however, the effects of these adjuvant
therapies could not be proved because of the rare-
ness of this disease (5, 8). The prognosis of ovarian
leiomyosarcoma is extremely poor, and it depends
on the tumor stage, tumor size, and MI (2, 5, 9, 10).
Taskin, et al. reported that 63.3% of stage-1 patients
survived with no evidence of the disease after a
mean follow-up period of 41.7 months, while 81.25%
of patients at a higher stage died after a mean follow-
up period of only 14.7 months (5).
Unfortunately, fewer cases were reported on
STUMP of the ovary compared with leiomyosar-
coma of the ovary which is a still very rare disease.
Lerwill, et al. reported that total abdominal hyster-
ectomy and bilateral salpingo-oophorectomy were
performed in one case, unilateral salpingo-oophorec-
tomy in one, and unilateral oophorectomy in two
cases. Only three patients could be followed up after
the operation : the follow-up report for one was not
available because it was recent, while the disease
recurred in the other two patients (at 16 months for
one and at 58 months for the other patient) (2).
We encountered a huge ovarian tumor which fea-
tures are intermediate between leiomyoma and leio-
myosarcoma. We presumed that the patient had a
stage-1 tumor, and the minimum surgery of RSO
was performed.
This patient and her family did not wish for fur-
ther therapy. There is no established treatment pro-
tocol other than surgery, which is the mainstay of
treatment. Various adjuvant therapies have been pro-
posed, including radiotherapy and chemotherapy,
with no additional benefit (5, 8). However, careful
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observations should be required in this case because
the huge tumor size might indicate a high malig-
nancy potential.
Because ovarian smooth muscle tumors are very
rare, it was difficult to assess the histological find-
ings in our patient. In light of this case report, we
think that it is important to establish criteria for the
differential diagnosis of ovarian smooth muscle tu-
mors.
Further information is required regarding the
characteristics of ovarian smooth muscle tumors and
the propriety to introduce uterine tumor histological
criteria to ovarian tumors.
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